AC Immune SA

From Verify.Wiki
Jump to: navigation, search
AC Immune SA
Type Public
Industry Biotechnology
Founded 2003
Headquarters Lausanne, Switzerland
Key people Andrea Pfeifer (Co-Founder & CEO), Jean-Fabien Monin (CFO), Andreas Muhs (CSO) [1]
Investors Dietmar Hopp
Number of employees 62 [2]

AC Immune SA, a clinical stage Swiss-based biopharmaceutical company, focuses on neurodegenerative diseases with three product candidates in clinical trials. It designs, discovers, and develops therapeutic and diagnostic products intended to prevent and modify diseases caused by misfolding proteins. The company’s technology platforms create antibodies, small molecules, and vaccines to address a broad spectrum of neurodegenerative indications. It offers its therapies to address Alzheimer disease and neurodegenerative diseases, such as Parkinson’s, Down syndrome, and glaucoma.
AC Immune SA was founded in 2003 and is based in Lausanne, Switzerland. [3]



Top 5 Recent Tweets

May 24, 2018LootMountain💰⛰️ A New Kind of Stock Chart: AC Immune SA ( NASDAQ :ACIU) Critical Pivot Points. AC Immune SA ( NASDAQ :ACIU) Cri…
May 23, 2018ShootForLife Using the immune system to defeat cancer - The Institute of Cancer Research
May 22, 2018OlympiaReportAnalysts Expect AC Immune SA $ACIU to Announce -$0.23 Earnings Per Share
May 22, 2018wosaikenerikiCould AC Immune SA (ACIU) See a Reversal After Having Formed Several Months Bearish Head & Shoulde...

Top 5 Recent News Headlines

Top 5 Lifetime Tweets

Top 5 Lifetime News Headlines


Verification history